Loading…
Cosmetic Modernization Amendments of 2017
Legislative Progress
Momentum (last 30 days)
0
score
0 actions · 0 new cosponsors · 0 votes
Speed vs cohort
0pct
0d open
vs 7,393 other HR bills in the 115th — cohort avg 50d
Cosmetic Modernization Amendments of 2017 This bill amends the Federal Food, Drug, and Cosmetic Act to set forth provisions governing the regulation of cosmetics by the Food and Drug Administration (FDA), including requiring the registration of manufacturing establishments and the submission of a cosmetic and ingredient statement for each cosmetic. The FDA must publish a list of registered establishments and a list of cosmetics and their ingredients. Cosmetic manufacturers, packers, and distributors must report to the FDA any serious and unexpected adverse events likely caused by a cosmetic. Cosmetic labels must include contact information to report a serious adverse event. The FDA may establish principles and standards for good manufacturing practices for cosmetics. A cosmetic may not be sold if it presents a significant risk of serious adverse health consequences because it was not manufactured in accordance with good manufacturing practices. Certain ingredients are deemed safe for use in cosmetics unless restricted by the FDA. The FDA must establish a program to evaluate the safety of cosmetics and cosmetic ingredients. The FDA must establish and maintain a National Cosmetic Regulatory Databank that contains submitted information on cosmetics. Confidential business and trade secret information may be disclosed only to state agencies that request this information for good cause. The FDA may establish exemptions to requirements so that implementation and compliance is cost-effective. Color additives that the FDA has not listed as suitable and safe but that are generally recognized as safe may be used in cosmetics. States and local governments may not establish or continue in effect specified requirements relating to cosmetics. Cosmetics may only be imported from registered establishments that have submitted a cosmetic and ingredient statement.
These links require the bill number to appear in the filing's source-reported specific issue text. Client expenses and lobbying-firm income are separate disclosure fields.
Filing registrants (14)
Referred to the House Committee on Energy and Commerce.
Introduced in House
Congress.gov source codes: 1000, Intro-H
Bills with similar content found using semantic analysis.
Sources: Congress.gov
2018 · second_quarter · Health Issues
Cosmetic safety legislation including: H.R.575, Cosmetic Modernization Amendments of 2017 and S.1113, Personal Care Product Safety Act.
Client expense: $290,000 · Firm income: Not reported
Government targets: Commerce, Dept of (DOC), Energy, Dept of, Environmental Protection Agency (EPA), HOUSE OF REPRESENTATIVES, Natl Economic Council (NEC), SENATE, State, Dept of (DOS), Treasury, Dept of
2018 · fourth_quarter · Health Issues
Cosmetic safety legislation, including: H.R.575, Cosmetic Modernization Amendments of 2017 and S.1113, Personal Care Product Safety Act. Opioid legislation affecting the industry, including: H.R.6, SUPPORT for Patients and Communities Act (P.L.115-271).
Client expense: $250,000 · Firm income: Not reported
Government targets: Commerce, Dept of (DOC), Energy, Dept of, Environmental Protection Agency (EPA), Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Natl Economic Council (NEC), Natl Security Council (NSC), SENATE, State, Dept of (DOS), Treasury, Dept of, U.S. Trade Representative (USTR)
2018 · second_quarter · Health Issues
Cosmetic safety legislation including: H.R.575, Cosmetic Modernization Amendments of 2017 and S.1113, Personal Care Product Safety Act.
Client expense: $260,000 · Firm income: Not reported
Government targets: Commerce, Dept of (DOC), Energy, Dept of, Environmental Protection Agency (EPA), HOUSE OF REPRESENTATIVES, Natl Economic Council (NEC), SENATE, State, Dept of (DOS), Treasury, Dept of
2018 · fourth_quarter · Consumer Issues/Safety/Products
H.R. 575, Cosmetic Modernization Amendments of 2017; S. 1113, Personal Care Products Safety Act; S. 2003, FDA Cosmetic Safety and Modernization Act; Modernization of Cosmetics Regulation Act of 2018 (S. HELP Committee discussion draft); Issues related to sunscreen regulations
Client expense: $370,000 · Firm income: Not reported
Government targets: Executive Office of the President (EOP), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Natl Economic Council (NEC), Office of the Vice President of the United States, SENATE, U.S. Trade Representative (USTR)
2018 · fourth_quarter · Consumer Issues/Safety/Products
H.R. 906 (Furthering Asbestos Claims Transparency Act); amends title 11 of the United States Code to require the public disclosure by trusts established under section 524(g) of such title, of quarterly reports that contain detailed information regarding the receipt and disposition of claims for injuries based on exposure to asbestos. H.R. 1563 (Mary Jo Lawyer Spano Mesothelioma Patient Registry Act of 2017); amends the Public Health Service Act to provide for the establishment of a mesothelioma patient registry. H.R. 575 (Cosmetic Modernization Amendments of 2017); amends the Federal Food, Drug, and Cosmetic Act to establish new procedures and requirements for the registration of cosmetic manufacturing establishments, the submission of cosmetic and ingredient statements, and the reporting of serious cosmetic adverse events. S. 1113 (Personal Care Products Safety Act); amends the Federal Food, Drug, and Cosmetic Act to ensure the safety of cosmetics. H.R. 832 (Arbitration Transparency Act); amends title 9 of the United States Code to require that arbitration proceedings in certain disputes involving consumer financial products and services be open to the public. S. 542 (Safety Over Arbitration Act of 2017); amends title 9, United States Code, with respect to arbitration where the claim or controversy alleges facts relevant to a hazard to public health or safety. S. 552/H.R. 1414 (Justice for Victims of Fraud Act); amends the Truth in Lending Act and the Electronic Fund Transfer Act to provide justice to victims of fraud. S. 550/H.R. 1396 (Restoring Statutory Rights Act); invalidates arbitration agreements between parties in certain commercial contracts or transactions if they require arbitration of a claim for damages or injunctive relief brought by an individual or small business arising from the alleged violation of a federal or state statute, the U.S. Constitution, or a state constitution. S. 646/H.R. 2631 (Justice for Servicemembers and Veterans Act); amends title 38, United States Code, to improve the enforcement of employment and reemployment rights of members of the uniformed services, to amend the Servicemembers Civil Relief Act to improve the protection of members of the uniformed services. S. 647 (Mandatory Arbitration Transparency Act); amends title 9, United States Code, with respect to arbitration. S. 537/H.R. 1374 (Arbitration Fairness Act); prohibits mandatory, pre-dispute arbitration in employment, consumer, antitrust, or civil rights disputes. S. 2203/H.R. 4734/H.R. 4570 (Ending Forced Arbitration of Sexual Harassment Act of 2017); prohibits a pre-dispute arbitration agreement from being valid or enforceable if it requires arbitration of a sex discrimination dispute. H.R. 3857 (PASS Act of 2017); amend the Securities Exchange Act of 1934 to lower standards of conduct for brokers and dealers that are in the best interest of their retail customers. S. 534/H.R. 1973 (Protecting Young Victims from Sexual Abuse Act of 2017); prevents the sexual abuse of minors and amateur athletes by requiring the prompt reporting of sexual abuse to law enforcement authorities S. 2564, (PROTECT Asbestos Victims Act of 2018); restricts claims against asbestos trusts and provides for criminal penalties for fraudulent claims. S. 1112, (Maternal Health Accountability Act of 2017); retricts the use of information reviewed by the maternal mortality review committee. Infomration is considered confidential and not subject to dioscvery at a civil trial. S. 2852 (Pandemic and All-Hazards Preparedness and Advancing Innovation Act of 2018); regarding immunity provisions, and additional variations of the bill including: H.R. 7328 (Pandemic and All-Hazards Preparedness and Advancing Innovation Act of 2018) and H.R. 6378 (Pandemic and All-Hazards Preparedness and Advancing Innovation Act of 2018). H.R. 6022/ S. 3019 (Accurate Labels Act); regarding the broad preemption of state and local labeling laws for consumer products. H.R. 6903 (Safe Cosmetics and Personal Care Products Act of 2018); amends current law to ensure the safety of cosmetics and personal care products. H.R. 919 (Blitz Gas Can bill). H.R. 3850 (Made in America Act of 2017); directs the FTC to establish labels that may be used as a voluntary means of indicating to consumers the extent to which products are of US origin; more specifically about the FTC enforcement authority. General issues pertaining to Asbestos Bankruptcy Trusts. Cosmetic Regulation and Safety and realted preemption issues in Murray Alexander draft bill. General lobbying with regard to the Education Departments borrower defenses rule. General lobbying with regard to warranties of Energy Star-rated products and ability of consumers to bring a class action against manufacturers of Energy Star-rated products. General lobbying with regard to pesticide regulations. General lobbying with regard to amending Telephone Consumer Protection Act liability. General lobbying with regard to attorney advertising issues. General lobbying with regard to asbestos exposure and related health and environmental issues. General lobbying with regard to liability issues related to regulation of cosmetics products. General lobbying with regard to TSCA implementation. General lobbying with regard to asbestos in talc and talc generally. General lobbying with regard to nursing home arbitration. General lobbying with regard to issues relating to PFOA.
Client expense: $1,300,000 · Firm income: Not reported
Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE, Securities & Exchange Commission (SEC)
2018 · fourth_quarter · Health Issues
Administrative and legislative monitoring and outreach on issues related to cosmetic regulation and reform. H.R. 575, Cosmetic Modernization Amendments of 2017. S. 1113, Personal Care Products Safety Act. S. 2003, FDA Cosmetic Safety and Modernization Act.
Client expense: Not reported · Firm income: $60,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2018 · fourth_quarter · Health Issues
- S. 469/H.R. 1245, "Affordable and Safe Prescription Drug Importation Act", regarding all provisions. - S. 771/H.R. 1776, "Improving Access To Affordable Prescription Drugs Act", regarding all provisions. - H.R. 575, "Cosmetic Modernization Amendments of 2017", regarding all provisions. - H.R. 1271, "DXM Abuse Prevention Act of 2017", regarding all provisions. - S. 404/H.R. 1736, "To amend the Federal Food, Drug, and Cosmetic Act to improve the process for inspections of device establishments and for granting export certifications.", regarding all provisions. - Issues regarding drug pricing. - Issues related to diagnostic reform. - S 260/SJ Res 17/HR 849, Protecting Seniors' Access to Medicare Act of 2017, regarding all provisions - S 251/SJ Res 16, Protecting Medicare from Executive Action Act of 2017, regarding all provisions - S 204/HR 878, Right to Try Act of 2017, regarding all provisions - HR 2026, Pharmaceutical Information Exchange Act, regarding all provisions - HR 1703, Medical Product Communications Act of 2017, regarding all provisions - Issues related to VA procurement of medical devices - HR 2474, Medical Product Review Harmonization Act, regarding all provisions - HR 2144, Risk Based Classification of Accessories Act - Issues related to AMA resolution 208(A-16) regarding attorney ads on drug side effects - S.1113, "Personal Care Products Safety Act", regarding all provisions - HR 2790, "Humane Cosmetics Act", regarding all provisions - HR 3271, "Protecting Access to Diabetes Supplies Act", regarding all provisions - Issues regarding medical device repeal - Issues regarding NIH Funding - HR 2164, "Medical Device Safety Act", regarding all provisions - Issues related to 340B - Issues related to HIV vaccines - S. 2852, "Pandemic & All Hazards Preparedness and Advancing Innovations Act of 2018", regarding all provisions. - Issues related to reauthorization of the Pandemic All-Hazards Preparedness Act programs. (House version) - HR 5492, "MOTHER Act of 2018", regarding all provisions. - Issues related to access to essential surgery - Issues related to contact lens safety - HR 6, "SUPPORT for Patients and Communities Act", regarding all provisions. - S. 2315, "Over-the-Counter Drug Safety, Innovation, and Reform Act", regarding all provisions. - HR 5333 "Over-the-Counter Monograph Safety, Innovation, and Reform Act of 2018", regarding all provisions. - Issues related to antimicrobial resistance - Issues related to regulations on medication product packaging - H.R. 6294, " Re-Valuing Anti-Microbial Products Act of 2018", regarding all provisions - H.R. 1318, "Preventing Maternal Deaths Act of 2018", regarding all provisions
Client expense: $2,340,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE, Veterans Affairs, Dept of (VA), White House Office
2018 · fourth_quarter · Consumer Issues/Safety/Products
Legislation relating to Cosmetics Reform (chemical safety, cosmetic ingredient safety, and disclosure of fragrance ingredients in consumer products). HR 575; S 1113; S 2003; HR 4964; HR 6903, all provisions. Formation of Congressional Fragrance Caucus.
Client expense: $80,000 · Firm income: Not reported
Government targets: Environmental Protection Agency (EPA), HOUSE OF REPRESENTATIVES, SENATE
2018 · fourth_quarter · Health Issues
Cosmetic safety legislation, including: H.R.575, Cosmetic Modernization Amendments of 2017 and S.1113, Personal Care Product Safety Act. Opioid legislation affecting the industry, including: H.R.6, SUPPORT for Patients and Communities Act (P.L.115-271).
Client expense: $230,000 · Firm income: Not reported
Government targets: Commerce, Dept of (DOC), Energy, Dept of, Environmental Protection Agency (EPA), Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Natl Economic Council (NEC), Natl Security Council (NSC), SENATE, State, Dept of (DOS), Treasury, Dept of, U.S. Trade Representative (USTR)
2018 · fourth_quarter · Health Issues
Cosmetic safety legislation including: H.R.575, Cosmetic Modernization Amendments of 2017 and S.1113, Personal Care Product Safety Act. H.R.6 SUPPORT for Patients and Communities Act (P.L.115-271)
Client expense: Not reported · Firm income: $30,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2018 · fourth_quarter · Consumer Issues/Safety/Products
H.R. 575 - Cosmetic Modernization Amendments of 2017 S. 1113 - Personal Care Products Safety Act. Issues related to sunscreen regulations.
Client expense: Not reported · Firm income: $80,000
Government targets: Executive Office of the President (EOP), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Natl Economic Council (NEC), Office of the Vice President of the United States, SENATE, U.S. Trade Representative (USTR)
2018 · fourth_quarter · Consumer Issues/Safety/Products
Modernization of Cosmetic Regulations H.R. 575 - Cosmetic Modernization Amendments of 2017 S. 1113 - Personal Care Products Safety Act Safety of Cosmetic/Personal Care/Household Cleaning Products & Ingredients FDA Regulation of OTC Drugs OTC Drug Monograph Reform - H.R. 5333 & S. 2315 Ingredient Disclosure - Cleaning Products
Client expense: Not reported · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2018 · fourth_quarter · Health Issues
SB 1113 - Feinstein/Collins The Personal Care Product Safety Act, Lance/Pallone proposal to reform the current Cosmetic Safety legislation. Senator Hatch Bill on Cosmetic Reform S.2003 Congressman Sessions Cosmetic Reform HR 575
Client expense: Not reported · Firm income: $30,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2018 · second_quarter · Consumer Issues/Safety/Products
H.R. 906 (Furthering Asbestos Claims Transparency Act); amends title 11 of the United States Code to require the public disclosure by trusts established under section 524(g) of such title, of quarterly reports that contain detailed information regarding the receipt and disposition of claims for injuries based on exposure to asbestos. H.R. 1563 (Mary Jo Lawyer Spano Mesothelioma Patient Registry Act of 2017); amends the Public Health Service Act to provide for the establishment of a mesothelioma patient registry. H.R. 575 (Cosmetic Modernization Amendments of 2017); amends the Federal Food, Drug, and Cosmetic Act to establish new procedures and requirements for the registration of cosmetic manufacturing establishments, the submission of cosmetic and ingredient statements, and the reporting of serious cosmetic adverse events. S. 1113 (Personal Care Products Safety Act); amends the Federal Food, Drug, and Cosmetic Act to ensure the safety of cosmetics. H.R. 832 (Arbitration Transparency Act); amends title 9 of the United States Code to require that arbitration proceedings in certain disputes involving consumer financial products and services be open to the public. S. 542 (Safety Over Arbitration Act of 2017); amends title 9, United States Code, with respect to arbitration where the claim or controversy alleges facts relevant to a hazard to public health or safety. S. 552/H.R. 1414 (Justice for Victims of Fraud Act); amends the Truth in Lending Act and the Electronic Fund Transfer Act to provide justice to victims of fraud. S. 550/H.R. 1396 (Restoring Statutory Rights Act); invalidates arbitration agreements between parties in certain commercial contracts or transactions if they require arbitration of a claim for damages or injunctive relief brought by an individual or small business arising from the alleged violation of a federal or state statute, the U.S. Constitution, or a state constitution. S. 646/H.R. 2631 (Justice for Servicemembers and Veterans Act); amends title 38, United States Code, to improve the enforcement of employment and reemployment rights of members of the uniformed services, to amend the Servicemembers Civil Relief Act to improve the protection of members of the uniformed services. S. 647 (Mandatory Arbitration Transparency Act); amends title 9, United States Code, with respect to arbitration. S. 537/H.R. 1374 (Arbitration Fairness Act); prohibits mandatory, pre-dispute arbitration in employment, consumer, antitrust, or civil rights disputes. S. 2203/H.R. 4734/H.R. 4570 (Ending Forced Arbitration of Sexual Harassment Act of 2017); prohibits a pre-dispute arbitration agreement from being valid or enforceable if it requires arbitration of a sex discrimination dispute. H.R. 3857 (PASS Act of 2017); amend the Securities Exchange Act of 1934 to lower standards of conduct for brokers and dealers that are in the best interest of their retail customers. S. 534/H.R. 1973 (Protecting Young Victims from Sexual Abuse Act of 2017); prevents the sexual abuse of minors and amateur athletes by requiring the prompt reporting of sexual abuse to law enforcement authorities S. 2564, (PROTECT Asbestos Victims Act of 2018); restricts claims against asbestos trusts and provides for criminal penalties for fraudulent claims. S. 1112, (Maternal Health Accountability Act of 2017); retricts the use of information reviewed by the maternal mortality review committee. Infomration is considered confidential and not subject to dioscvery at a civil trial. S. 2852 (Pandemic and All-Hazards Preparedness and Advancing Innovation Act of 2018); regarding immunity provisions. H.R. 6022/ S. 3019 (Accurate Labels Act); regarding the broad preemption of state and local labeling laws for consumer products. Cosmetic Regulation and Safety and realted preemption issues in Murray Alexander draft bill. General lobbying with regard to the Education Departments borrower defenses rule. General lobbying with regard to warranties of Energy Star-rated products and ability of consumers to bring a class action against manufacturers of Energy Star-rated products. General lobbying with regard to pesticide regulations. General lobbying with regard to amending Telephone Consumer Protection Act liability. General lobbying with regard to attorney advertising issues. General lobbying with regard to asbestos exposure and related health and environmental issues. General lobbying with regard to liability issues related to regulation of cosmetics products. General lobbying with regard to TSCA implementation.
Client expense: $1,430,000 · Firm income: Not reported
Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
2018 · third_quarter · Health Issues
SB 1113 - Feinstein/Collins The Personal Care Product Safety Act, Lance/Pallone proposal to reform the current Cosmetic Safety legislation. Senator Hatch Bill on Cosmetic Reform S.2003 Congressman Sessions Cosmetic Reform HR 575
Client expense: Not reported · Firm income: $30,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2018 · third_quarter · Health Issues
Cosmetic safety legislation, including: H.R.575, Cosmetic Modernization Amendments of 2017 and S.1113, Personal Care Product Safety Act. Opioid legislation affecting the industry, including: H.R.6, SUPPORT for Patients and Communities Act, H.R.5228, SCREEN Act, H.R.5752, Stop Illicit Drug Importation Act of 2018, and S.2680, Opioid Crisis Response Act of 2018.
Client expense: $240,000 · Firm income: Not reported
Government targets: Commerce, Dept of (DOC), Energy, Dept of, Environmental Protection Agency (EPA), HOUSE OF REPRESENTATIVES, SENATE, State, Dept of (DOS), Treasury, Dept of
2018 · third_quarter · Consumer Issues/Safety/Products
H.R. 906 (Furthering Asbestos Claims Transparency Act); amends title 11 of the United States Code to require the public disclosure by trusts established under section 524(g) of such title, of quarterly reports that contain detailed information regarding the receipt and disposition of claims for injuries based on exposure to asbestos. H.R. 1563 (Mary Jo Lawyer Spano Mesothelioma Patient Registry Act of 2017); amends the Public Health Service Act to provide for the establishment of a mesothelioma patient registry. H.R. 575 (Cosmetic Modernization Amendments of 2017); amends the Federal Food, Drug, and Cosmetic Act to establish new procedures and requirements for the registration of cosmetic manufacturing establishments, the submission of cosmetic and ingredient statements, and the reporting of serious cosmetic adverse events. S. 1113 (Personal Care Products Safety Act); amends the Federal Food, Drug, and Cosmetic Act to ensure the safety of cosmetics. H.R. 832 (Arbitration Transparency Act); amends title 9 of the United States Code to require that arbitration proceedings in certain disputes involving consumer financial products and services be open to the public. S. 542 (Safety Over Arbitration Act of 2017); amends title 9, United States Code, with respect to arbitration where the claim or controversy alleges facts relevant to a hazard to public health or safety. S. 552/H.R. 1414 (Justice for Victims of Fraud Act); amends the Truth in Lending Act and the Electronic Fund Transfer Act to provide justice to victims of fraud. S. 550/H.R. 1396 (Restoring Statutory Rights Act); invalidates arbitration agreements between parties in certain commercial contracts or transactions if they require arbitration of a claim for damages or injunctive relief brought by an individual or small business arising from the alleged violation of a federal or state statute, the U.S. Constitution, or a state constitution. S. 646/H.R. 2631 (Justice for Servicemembers and Veterans Act); amends title 38, United States Code, to improve the enforcement of employment and reemployment rights of members of the uniformed services, to amend the Servicemembers Civil Relief Act to improve the protection of members of the uniformed services. S. 647 (Mandatory Arbitration Transparency Act); amends title 9, United States Code, with respect to arbitration. S. 537/H.R. 1374 (Arbitration Fairness Act); prohibits mandatory, pre-dispute arbitration in employment, consumer, antitrust, or civil rights disputes. S. 2203/H.R. 4734/H.R. 4570 (Ending Forced Arbitration of Sexual Harassment Act of 2017); prohibits a pre-dispute arbitration agreement from being valid or enforceable if it requires arbitration of a sex discrimination dispute. H.R. 3857 (PASS Act of 2017); amend the Securities Exchange Act of 1934 to lower standards of conduct for brokers and dealers that are in the best interest of their retail customers. S. 534/H.R. 1973 (Protecting Young Victims from Sexual Abuse Act of 2017); prevents the sexual abuse of minors and amateur athletes by requiring the prompt reporting of sexual abuse to law enforcement authorities S. 2564, (PROTECT Asbestos Victims Act of 2018); restricts claims against asbestos trusts and provides for criminal penalties for fraudulent claims. S. 1112, (Maternal Health Accountability Act of 2017); retricts the use of information reviewed by the maternal mortality review committee. Infomration is considered confidential and not subject to dioscvery at a civil trial. S. 2852 (Pandemic and All-Hazards Preparedness and Advancing Innovation Act of 2018); regarding immunity provisions. H.R. 6022/ S. 3019 (Accurate Labels Act); regarding the broad preemption of state and local labeling laws for consumer products. H.R. 6903 (Safe Cosmetics and Personal Care Products Act of 2018); amends current law to ensure the safety of cosmetics and personal care products. H.R. 919 (Blitz Gas Can bill). General issues pertaining to Asbestos Bankruptcy Trusts. Cosmetic Regulation and Safety and realted preemption issues in Murray Alexander draft bill. General lobbying with regard to the Education Departments borrower defenses rule. General lobbying with regard to warranties of Energy Star-rated products and ability of consumers to bring a class action against manufacturers of Energy Star-rated products. General lobbying with regard to pesticide regulations. General lobbying with regard to amending Telephone Consumer Protection Act liability. General lobbying with regard to attorney advertising issues. General lobbying with regard to asbestos exposure and related health and environmental issues. General lobbying with regard to liability issues related to regulation of cosmetics products. General lobbying with regard to TSCA implementation.
Client expense: $1,510,000 · Firm income: Not reported
Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE, Securities & Exchange Commission (SEC)
2018 · third_quarter · Consumer Issues/Safety/Products
H.R. 575, Cosmetic Modernization Amendments of 2017; S. 1113, Personal Care Products Safety Act; S. 2003, FDA Cosmetic Safety and Modernization Act; Issues related to sunscreen regulations
Client expense: $480,000 · Firm income: Not reported
Government targets: Executive Office of the President (EOP), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Natl Economic Council (NEC), Office of the Vice President of the United States, SENATE, U.S. Trade Representative (USTR)
2018 · third_quarter · Health Issues
Cosmetic safety legislation including: H.R.575, Cosmetic Modernization Amendments of 2017 and S.1113, Personal Care Product Safety Act. H.R.6 SUPPORT for Patients and Communities Act H.R.5228 SCREEN Act H.R. 5752 Stop Illicit Drug Importation Act of 2018 S. 2680 Opioid Crisis Response Act of 2018
Client expense: Not reported · Firm income: $30,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2018 · third_quarter · Health Issues
- S. 469/H.R. 1245, "Affordable and Safe Prescription Drug Importation Act", regarding all provisions. - S. 771/H.R. 1776, "Improving Access To Affordable Prescription Drugs Act", regarding all provisions. - H.R. 575, "Cosmetic Modernization Amendments of 2017", regarding all provisions. - H.R. 1271, "DXM Abuse Prevention Act of 2017", regarding all provisions. - S. 404/H.R. 1736, "To amend the Federal Food, Drug, and Cosmetic Act to improve the process for inspections of device establishments and for granting export certifications.", regarding all provisions. - Issues regarding drug pricing. - Issues related to diagnostic reform. - S 260/SJ Res 17/HR 849, Protecting Seniors' Access to Medicare Act of 2017, regarding all provisions - S 251/SJ Res 16, Protecting Medicare from Executive Action Act of 2017, regarding all provisions - S 204/HR 878, Right to Try Act of 2017, regarding all provisions - HR 2026, Pharmaceutical Information Exchange Act, regarding all provisions - HR 1703, Medical Product Communications Act of 2017, regarding all provisions - Issues related to VA procurement of medical devices - HR 2474, Medical Product Review Harmonization Act, regarding all provisions - HR 2144, Risk Based Classification of Accessories Act - Issues related to AMA resolution 208(A-16) regarding attorney ads on drug side effects - S.1113, "Personal Care Products Safety Act", regarding all provisions - HR 2790, "Humane Cosmetics Act", regarding all provisions - HR 3271, "Protecting Access to Diabetes Supplies Act", regarding all provisions - Issues regarding medical device repeal - Issues regarding NIH Funding - HR 2164, "Medical Device Safety Act", regarding all provisions - Issues related to 340B - Issues related to HIV vaccines - S. 2852, "Pandemic & All Hazards Preparedness and Advancing Innovations Act of 2018", regarding all provisions. - Issues related to reauthorization of the Pandemic All-Hazards Preparedness Act programs. (House version) - HR 5492, "MOTHER Act of 2018", regarding all provisions. - Issues related to access to essential surgery - Issues related to contact lens safety - HR 6, "SUPPORT for Patients and Communities Act", regarding all provisions. - S. 2315, "Over-the-Counter Drug Safety, Innovation, and Reform Act", regarding all provisions. - HR 5333 "Over-the-Counter Monograph Safety, Innovation, and Reform Act of 2018", regarding all provisions. - Issues related to antimicrobial resistance - Issues related to regulations on medication product packaging - H.R. 6294, " Re-Valuing Anti-Microbial Products Act of 2018", regarding all provisions
Client expense: $1,980,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE, Veterans Affairs, Dept of (VA), White House Office
2018 · third_quarter · Consumer Issues/Safety/Products
Legislation relating to chemical safety, cosmetic ingredients safety, and disclosure of fragrance ingredients in consumer products S. 1113 (Personal Care Products Safety Act), all provisions S. 2003 (FDA Cosmetic Safety and Modernization Act), all provisions H.R.575 (Cosmetic Modernization Amendments of 2017), all provisions H.R. 4964 (Children's Product Warning Label Act of 2018), all provisions H.R. 6903 (Safe Cosmetics and Personal Care Products Act of 2018), all provisions Formation of Congressional Fragrance Caucus
Client expense: Not reported · Firm income: $30,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2018 · third_quarter · Consumer Issues/Safety/Products
Legislation relating to Cosmetics Reform (chemical safety, cosmetic ingredient safety, and disclosure of fragrance ingredients in consumer products). HR 575; S 1113; S 2003; HR 4964; HR 6903, all provisions. Formation of Congressional Fragrance Caucus.
Client expense: $80,000 · Firm income: Not reported
Government targets: Environmental Protection Agency (EPA), HOUSE OF REPRESENTATIVES, SENATE
2018 · third_quarter · Consumer Issues/Safety/Products
H.R. 575 - Cosmetic Modernization Amendments of 2017 S. 1113 - Personal Care Products Safety Act. Issues related to sunscreen regulations.
Client expense: Not reported · Firm income: $80,000
Government targets: Executive Office of the President (EOP), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Natl Economic Council (NEC), Office of the Vice President of the United States, SENATE, U.S. Trade Representative (USTR)
2018 · third_quarter · Health Issues
Administrative and legislative monitoring and outreach on issues related to cosmetic regulation and reform. H.R. 575, Cosmetic Modernization Amendments of 2017. S. 1113, Personal Care Products Safety Act. S. 2003, FDA Cosmetic Safety and Modernization Act.
Client expense: Not reported · Firm income: $60,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2018 · third_quarter · Consumer Issues/Safety/Products
Modernization of Cosmetic Regulations H.R. 575 - Cosmetic Modernization Amendments of 2017 S. 1113 - Personal Care Products Safety Act Safety of Cosmetic/Personal Care/Household Cleaning Products & Ingredients FDA Regulation of OTC Drugs OTC Drug Monograph Reform - H.R. 5333 & S. 2315 Ingredient Disclosure - Cleaning Products
Client expense: Not reported · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2018 · second_quarter · Consumer Issues/Safety/Products
Legislation relating to chemical safety, cosmetic ingredients safety, and disclosure of fragrance ingredients in consumer products S. 1113 (Personal Care Products Safety Act), all provisions S. 2003 (FDA Cosmetic Safety and Modernization Act), all provisions H.R.575 (Cosmetic Modernization Amendments of 2017), all provisions H.R. 4964 (Children's Product Warning Label Act of 2018), all provisions Formation of Congressional Fragrance Caucus
Client expense: Not reported · Firm income: $40,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2018 · second_quarter · Health Issues
Administrative and legislative monitoring and outreach on issues related to cosmetic regulation and reform. H.R. 575, Cosmetic Modernization Amendments of 2017. S. 1113, Personal Care Products Safety Act. S. 2003, FDA Cosmetic Safety and Modernization Act.
Client expense: Not reported · Firm income: $20,000
Government targets: HOUSE OF REPRESENTATIVES
2018 · second_quarter · Consumer Issues/Safety/Products
H.R. 906 (Furthering Asbestos Claims Transparency Act); amends title 11 of the United States Code to require the public disclosure by trusts established under section 524(g) of such title, of quarterly reports that contain detailed information regarding the receipt and disposition of claims for injuries based on exposure to asbestos. H.R. 1563 (Mary Jo Lawyer Spano Mesothelioma Patient Registry Act of 2017); amends the Public Health Service Act to provide for the establishment of a mesothelioma patient registry. H.R. 575 (Cosmetic Modernization Amendments of 2017); amends the Federal Food, Drug, and Cosmetic Act to establish new procedures and requirements for the registration of cosmetic manufacturing establishments, the submission of cosmetic and ingredient statements, and the reporting of serious cosmetic adverse events. S. 1113 (Personal Care Products Safety Act); amends the Federal Food, Drug, and Cosmetic Act to ensure the safety of cosmetics. H.R. 832 (Arbitration Transparency Act); amends title 9 of the United States Code to require that arbitration proceedings in certain disputes involving consumer financial products and services be open to the public. S. 542 (Safety Over Arbitration Act of 2017); amends title 9, United States Code, with respect to arbitration where the claim or controversy alleges facts relevant to a hazard to public health or safety. S. 552/H.R. 1414 (Justice for Victims of Fraud Act); amends the Truth in Lending Act and the Electronic Fund Transfer Act to provide justice to victims of fraud. S. 550/H.R. 1396 (Restoring Statutory Rights Act); invalidates arbitration agreements between parties in certain commercial contracts or transactions if they require arbitration of a claim for damages or injunctive relief brought by an individual or small business arising from the alleged violation of a federal or state statute, the U.S. Constitution, or a state constitution. S. 646/H.R. 2631 (Justice for Servicemembers and Veterans Act); amends title 38, United States Code, to improve the enforcement of employment and reemployment rights of members of the uniformed services, to amend the Servicemembers Civil Relief Act to improve the protection of members of the uniformed services. S. 647 (Mandatory Arbitration Transparency Act); amends title 9, United States Code, with respect to arbitration. S. 537/H.R. 1374 (Arbitration Fairness Act); prohibits mandatory, pre-dispute arbitration in employment, consumer, antitrust, or civil rights disputes. S. 2203/H.R. 4734/H.R. 4570 (Ending Forced Arbitration of Sexual Harassment Act of 2017); prohibits a pre-dispute arbitration agreement from being valid or enforceable if it requires arbitration of a sex discrimination dispute. H.R. 3857 (PASS Act of 2017); amend the Securities Exchange Act of 1934 to lower standards of conduct for brokers and dealers that are in the best interest of their retail customers. S. 534/H.R. 1973 (Protecting Young Victims from Sexual Abuse Act of 2017); prevents the sexual abuse of minors and amateur athletes by requiring the prompt reporting of sexual abuse to law enforcement authorities S. 2564, (PROTECT Asbestos Victims Act of 2018); restricts claims against asbestos trusts and provides for criminal penalties for fraudulent claims. S. 1112, (Maternal Health Accountability Act of 2017); retricts the use of information reviewed by the maternal mortality review committee. Infomration is considered confidential and not subject to dioscvery at a civil trial. S. 2852 (Pandemic and All-Hazards Preparedness and Advancing Innovation Act of 2018); regarding immunity provisions. H.R. 6022/ S. 3019 (Accurate Labels Act); regarding the broad preemption of state and local labeling laws for consumer products. Cosmetic Regulation and Safety and realted preemption issues in Murray Alexander draft bill. General lobbying with regard to the Education Departments borrower defenses rule. General lobbying with regard to warranties of Energy Star-rated products and ability of consumers to bring a class action against manufacturers of Energy Star-rated products. General lobbying with regard to pesticide regulations. General lobbying with regard to amending Telephone Consumer Protection Act liability. General lobbying with regard to attorney advertising issues. General lobbying with regard to asbestos exposure and related health and environmental issues. General lobbying with regard to liability issues related to regulation of cosmetics products. General lobbying with regard to TSCA implementation.
Client expense: $1,430,000 · Firm income: Not reported
Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
2018 · second_quarter · Health Issues
Cosmetic safety legislation including: H.R.575, Cosmetic Modernization Amendments of 2017 and S.1113, Personal Care Product Safety Act.
Client expense: Not reported · Firm income: $30,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2018 · second_quarter · Consumer Issues/Safety/Products
Legislation relating to Cosmetics Reform (chemical safety, cosmetic ingredient safety, and disclosure of fragrance ingredients in consumer products). HR 575; S 1113; S 2003; HR 4964, all provisions. Formation of Congressional Fragrance Caucus.
Client expense: $80,000 · Firm income: Not reported
Government targets: Environmental Protection Agency (EPA), HOUSE OF REPRESENTATIVES, SENATE
2018 · second_quarter · Consumer Issues/Safety/Products
H.R. 575, Cosmetic Modernization Amendments of 2017; S. 1113, Personal Care Products Safety Act; S. 2003, FDA Cosmetic Safety and Modernization Act
Client expense: $510,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE, U.S. Trade Representative (USTR)
2018 · second_quarter · Health Issues
Cosmetic safety legislation including: H.R.575, Cosmetic Modernization Amendments of 2017 and S.1113, Personal Care Product Safety Act.
Client expense: $250,000 · Firm income: Not reported
Government targets: Commerce, Dept of (DOC), Energy, Dept of, Environmental Protection Agency (EPA), HOUSE OF REPRESENTATIVES, Natl Economic Council (NEC), SENATE, State, Dept of (DOS), Treasury, Dept of
2018 · second_quarter · Consumer Issues/Safety/Products
S. 2003 - The FDA Cosmetic Safety and Modernization Act, all sections. S. 1113 - Personal Care Products Safety Act, all sections. H.R.575 - Cosmetic Modernization Amendments of 2017, all sections. H.R. 5333-Over-the-Counter Monograph Safety, Innovation, and Reform Act of 2018, any sections pertaining to sunscreen and GRASE findings. S. 2315-Over-the-Counter Drug Safety, Innovation, and Reform Act, any sections pertaining to sunscreen and GRASE findings. S._____- Draft legislation to Amend the Federal Food, Drug, and Cosmetic Act to Ensure the Safety of Cosmetics. H.R. ______ - Draft legislation to Amend the Federal Food, Drug, and Cosmetic Act to Ensure the Safety of Cosmetics.
Client expense: $192,562 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2018 · second_quarter · Health Issues
- S. 469/H.R. 1245, "Affordable and Safe Prescription Drug Importation Act", regarding all provisions. - S. 771/H.R. 1776, "Improving Access To Affordable Prescription Drugs Act", regarding all provisions. - H.R. 575, "Cosmetic Modernization Amendments of 2017", regarding all provisions. - H.R. 1271, "DXM Abuse Prevention Act of 2017", regarding all provisions. - S. 404/H.R. 1736, "To amend the Federal Food, Drug, and Cosmetic Act to improve the process for inspections of device establishments and for granting export certifications.", regarding all provisions. - Issues regarding drug pricing. - Issues related to diagnostic reform. - S 260/SJ Res 17/HR 849, Protecting Seniors' Access to Medicare Act of 2017, regarding all provisions - S 251/SJ Res 16, Protecting Medicare from Executive Action Act of 2017, regarding all provisions - S 204/HR 878, Right to Try Act of 2017, regarding all provisions - HR 2026, Pharmaceutical Information Exchange Act, regarding all provisions - HR 1703, Medical Product Communications Act of 2017, regarding all provisions - Issues related to VA procurement of medical devices - HR 2474, Medical Product Review Harmonization Act, regarding all provisions - HR 2144, Risk Based Classification of Accessories Act - Issues related to AMA resolution 208(A-16) regarding attorney ads on drug side effects - S.1113, "Personal Care Products Safety Act", regarding all provisions - HR 2790, "Humane Cosmetics Act", regarding all provisions - Issues related to over the counter medicine regulatory reform - HR 3271, "Protecting Access to Diabetes Supplies Act", regarding all provisions - Issues regarding medical device repeal - Issues regarding NIH Funding - HR 2164, "Medical Device Safety Act", regarding all provisions - Issues related to 340B - Issues related to HIV vaccines - S. 2852, "Pandemic & All Hazards Preparedness and Advancing Innovations Act of 2018", regarding all provisions. - Issues related to reauthorization of the Pandemic All-Hazards Preparedness Act programs. (House version) - HR 5492, "MOTHER Act of 2018", regarding all provisions. - Issues related to access to essential surgery - Issues related to contact lens safety
Client expense: $870,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE, Veterans Affairs, Dept of (VA), White House Office
2018 · second_quarter · Consumer Issues/Safety/Products
H.R. 575 - Cosmetic Modernization Amendments of 2017 S. 1113 - Personal Care Products Safety Act.
Client expense: Not reported · Firm income: $90,000
Government targets: Executive Office of the President (EOP), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Natl Economic Council (NEC), Office of the Vice President of the United States, SENATE, U.S. Trade Representative (USTR)
2018 · second_quarter · Consumer Issues/Safety/Products
H.R.142, Dangerous Products Warning Act H.R.575, Cosmetic Modernization Amendments of 2017 H.R.2728, Cleaning Product Labeling Act of 2017 H.R.2790, Humane Cosmetics Act H.R.3409, Anti-Pyramid Promotional Scheme Act of 2017 H.R.4544, Consumer Data Protection Act H.R.5165, Ending Forced Arbitration for Victims of Data Breaches Act of 2018 H.R.5166, Protecting Consumer Information Act of 2018 H.R.5548, To require a study on the presence of personal care products in drinking water S.2003, FDA Cosmetic Safety and Modernization Act S.2124, Consumer Privacy Protection Act of 2017 S.2179, Data Security and Breach Notification Act
Client expense: $150,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2018 · second_quarter · Consumer Issues/Safety/Products
Modernization of Cosmetic Regulations H.R. 575 - Cosmetic Modernization Amendments of 2017 S. 1113 - Personal Care Products Safety Act Safety of Cosmetic/Personal Care/Household Cleaning Products & Ingredients FDA Regulation of OTC Drugs OTC Drug Monograph Reform - H.R. 5333 & S. 2315 Ingredient Disclosure - Cleaning Products
Client expense: Not reported · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2018 · first_quarter · Consumer Issues/Safety/Products
Legislation relating to Cosmetics Reform (chemical safety, cosmetic ingredient safety, and disclosure of fragrance ingredients in consumer products). HR 575; S 1113; S 2003; HR 4964, all provisions
Client expense: $80,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2018 · first_quarter · Consumer Issues/Safety/Products
H.R. 575, Cosmetic Modernization Amendments of 2017; S. 1113, Personal Care Products Safety Act; S. 2003, FDA Cosmetic Safety and Modernization Act
Client expense: $500,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE, U.S. Trade Representative (USTR)
2018 · first_quarter · Consumer Issues/Safety/Products
H.R.142, Dangerous Products Warning Act H.R.575, Cosmetic Modernization Amendments of 2017 H.R.2728, Cleaning Product Labeling Act of 2017 H.R.2790, Humane Cosmetics Act H.R.3409, Anti-Pyramid Promotional Scheme Act of 2017 H.R.4544, Consumer Data Protection Act H.R.5165, Ending Forced Arbitration for Victims of Data Breaches Act of 2018 H.R.5166, Protecting Consumer Information Act of 2018 H.R.5548, To require a study on the presence of personal care products in drinking water S.2003, FDA Cosmetic Safety and Modernization Act S.2124, Consumer Privacy Protection Act of 2017 S.2179, Data Security and Breach Notification Act
Client expense: $150,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2018 · first_quarter · Consumer Issues/Safety/Products
H.R. 575 - Cosmetic Modernization Amendments of 2017. S. 1113 - Personal Care Products Safety Act.
Client expense: Not reported · Firm income: $90,000
Government targets: Executive Office of the President (EOP), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE
2018 · first_quarter · Health Issues
- S. 469/H.R. 1245, "Affordable and Safe Prescription Drug Importation Act", regarding all provisions. - S. 771/H.R. 1776, "Improving Access To Affordable Prescription Drugs Act", regarding all provisions. - H.R. 575, "Cosmetic Modernization Amendments of 2017", regarding all provisions. - H.R. 1271, "DXM Abuse Prevention Act of 2017", regarding all provisions. - S. 404/H.R. 1736, "To amend the Federal Food, Drug, and Cosmetic Act to improve the process for inspections of device establishments and for granting export certifications.", regarding all provisions. - Issues regarding drug pricing. - Issues related to diagnostic reform. - Issues related to blood glucose meters. - S 260/SJ Res 17/HR 849, Protecting Seniors' Access to Medicare Act of 2017, regarding all provisions - S 251/SJ Res 16, Protecting Medicare from Executive Action Act of 2017, regarding all provisions - S 204/HR 878, Right to Try Act of 2017, regarding all provisions - HR 2026, Pharmaceutical Information Exchange Act, regarding all provisions - HR 1703, Medical Product Communications Act of 2017, regarding all provisions - Issues related to VA procurement of medical devices - HR 2474, Medical Product Review Harmonization Act, regarding all provisions - HR 2144, Risk Based Classification of Accessories Act - Issues related to AMA resolution 208(A-16) regarding attorney ads on drug side effects - S.1113, "Personal Care Products Safety Act", regarding all provisions - HR 2790, "Humane Cosmetics Act", regarding all provisions - Issues related to over the counter medicine regulatory reform - HR 3271, "Protecting Access to Diabetes Supplies Act", regarding all provisions - Issues regarding medical device repeal - Issues regarding NIH Funding - HR 2164, "Medical Device Safety Act", regarding all provisions - Issues related to 340B - Issues related to HIV vaccines - Issues related to reauthorization of the Pandemic All-Hazards Preparedness Act programs. - HR 5492, "MOTHER Act of 2018", regarding all provisions.
Client expense: $1,370,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE, Veterans Affairs, Dept of (VA), White House Office
2018 · first_quarter · Consumer Issues/Safety/Products
H.R. 906 (Furthering Asbestos Claims Transparency Act); amends title 11 of the United States Code to require the public disclosure by trusts established under section 524(g) of such title, of quarterly reports that contain detailed information regarding the receipt and disposition of claims for injuries based on exposure to asbestos. H.R. 1563 (Mary Jo Lawyer Spano Mesothelioma Patient Registry Act of 2017); amends the Public Health Service Act to provide for the establishment of a mesothelioma patient registry. H.R. 575 (Cosmetic Modernization Amendments of 2017); amends the Federal Food, Drug, and Cosmetic Act to establish new procedures and requirements for the registration of cosmetic manufacturing establishments, the submission of cosmetic and ingredient statements, and the reporting of serious cosmetic adverse events. S. 1113 (Personal Care Products Safety Act); amends the Federal Food, Drug, and Cosmetic Act to ensure the safety of cosmetics. H.R. 832 (Arbitration Transparency Act); amends title 9 of the United States Code to require that arbitration proceedings in certain disputes involving consumer financial products and services be open to the public. S. 542 (Safety Over Arbitration Act of 2017); amends title 9, United States Code, with respect to arbitration where the claim or controversy alleges facts relevant to a hazard to public health or safety. S. 552/H.R. 1414 (Justice for Victims of Fraud Act); amends the Truth in Lending Act and the Electronic Fund Transfer Act to provide justice to victims of fraud. S. 550/H.R. 1396 (Restoring Statutory Rights Act); invalidates arbitration agreements between parties in certain commercial contracts or transactions if they require arbitration of a claim for damages or injunctive relief brought by an individual or small business arising from the alleged violation of a federal or state statute, the U.S. Constitution, or a state constitution. S. 646/H.R. 2631 (Justice for Servicemembers and Veterans Act); amends title 38, United States Code, to improve the enforcement of employment and reemployment rights of members of the uniformed services, to amend the Servicemembers Civil Relief Act to improve the protection of members of the uniformed services. S. 647 (Mandatory Arbitration Transparency Act); amends title 9, United States Code, with respect to arbitration. S. 537/H.R. 1374 (Arbitration Fairness Act); prohibits mandatory, pre-dispute arbitration in employment, consumer, antitrust, or civil rights disputes. S. 2203/H.R. 4734/H.R. 4570 (Ending Forced Arbitration of Sexual Harassment Act of 2017); prohibits a pre-dispute arbitration agreement from being valid or enforceable if it requires arbitration of a sex discrimination dispute. H.R. 3857 (PASS Act of 2017); amend the Securities Exchange Act of 1934 to lower standards of conduct for brokers and dealers that are in the best interest of their retail customers. S. 534/H.R. 1973 (Protecting Young Victims from Sexual Abuse Act of 2017); prevents the sexual abuse of minors and amateur athletes by requiring the prompt reporting of sexual abuse to law enforcement authorities S. 2564, (PROTECT Asbestos Victims Act of 2018); restricts claims against asbestos trusts and provides for criminal penalties for fraudulent claims. General lobbying with regard to the Education Departments borrower defenses rule. General lobbying with regard to the CMS long term care rule. General lobbying with regard to warranties of Energy Star-rated products and ability of consumers to bring a class action against manufacturers of Energy Star-rated products. General lobbying with regard to pesticide regulations. General lobbying with regard to amending Telephone Consumer Protection Act liability. General lobbying with regard to attorney advertising issues. General lobbying with regard to asbestos exposure and related health and environmental issues. General lobbying with regard to liability issues related to regulation of cosmetics products. General lobbying with regard to TSCA implementation.
Client expense: $1,830,000 · Firm income: Not reported
Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Natl Highway Traffic Safety Administration (NHTSA), SENATE, Transportation, Dept of (DOT)
2018 · first_quarter · Consumer Issues/Safety/Products
Legislation relating to chemical safety, cosmetic ingredients safety, and disclosure of fragrance ingredients in consumer products S. 1113 (Personal Care Products Safety Act), all provisions S. 2003 (FDA Cosmetic Safety and Modernization Act), all provisions H.R.575 (Cosmetic Modernization Amendments of 2017), all provisions H.R. 4964 (Children's Product Warning Label Act of 2018), all provisions
Client expense: Not reported · Firm income: $40,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2018 · first_quarter · Health Issues
Cosmetic safety legislation including: H.R.575, Cosmetic Modernization Amendments of 2017 and S.1113, Personal Care Product Safety Act.
Client expense: $240,000 · Firm income: Not reported
Government targets: Commerce, Dept of (DOC), Energy, Dept of, Environmental Protection Agency (EPA), HOUSE OF REPRESENTATIVES, Natl Economic Council (NEC), SENATE, State, Dept of (DOS), Treasury, Dept of
2018 · first_quarter · Consumer Issues/Safety/Products
S. 2003 - The FDA Cosmetic Safety and Modernization Act, all sections; S. 1113 - Personal Care Products Safety Act, all sections; H.R.575 - Cosmetic Modernization Amendments of 2017, all sections; S._____- Draft legislation to Amend the Federal Food, Drug, and Cosmetic Act to Ensure the Safety of Cosmetics; H.R. ______ - Draft legislation to Amend the Federal Food, Drug, and Cosmetic Act to Ensure the Safety of Cosmetics.
Client expense: $139,495 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2018 · first_quarter · Consumer Issues/Safety/Products
Modernization of Cosmetic Regulations H.R. 575 - Cosmetic Modernization Amendments of 2017 S. 1113 - Personal Care Products Safety Act Safety of Cosmetic/Personal Care/Household Cleaning Products & Ingredients FDA Regulation of OTC Drugs OTC Drug Monograph Reform - H.R. 5333 & S. 2315 Ingredient Disclosure - Cleaning Products
Client expense: Not reported · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2018 · first_quarter · Health Issues
Cosmetic safety legislation including: H.R.575, Cosmetic Modernization Amendments of 2017 and S.1113, Personal Care Product Safety Act.
Client expense: Not reported · Firm income: $30,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2017 · fourth_quarter · Consumer Issues/Safety/Products
H.R.142, Dangerous Products Warning Act H.R.575, Cosmetic Modernization Amendments of 2017 H.R.2728, Cleaning Product Labeling Act of 2017 H.R.2790, Humane Cosmetics Act H.R.3409, Anti-Pyramid Promotional Scheme Act of 2017 H.R.4544, Consumer Data Protection Act H.R.5165, Ending Forced Arbitration for Victims of Data Breaches Act of 2018 H.R.5166, Protecting Consumer Information Act of 2018 S.2003, FDA Cosmetic Safety and Modernization Act S.2124, Consumer Privacy Protection Act of 2017 S.2179, Data Security and Breach Notification Act
Client expense: $150,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2017 · fourth_quarter · Consumer Issues/Safety/Products
H.R. 575, Cosmetic Modernization Amendments of 2017; S. 1113, Personal Care Products Safety Act; S. 2003, FDA Cosmetic Safety and Modernization Act
Client expense: $400,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE, U.S. Trade Representative (USTR)